Winning the votes of two of the leaders of the anti-Trump resistance in the Senate would seem like a long shot for Robert F. Kennedy Jr. in his bid to win confirmation as President-elect Donald Trump’s secretary of health and human services.

Then again, Ed Markey and Elizabeth Warren are Democrats who represent Massachusetts, and Kennedy is… a Kennedy, the son of a Democratic senator and nephew of two other Democratic senators.

Kennedy’s decision to meet with the Bay State’s Senate delegation on Thursday shows, to some political insiders, the lasting power of the Kennedy name in the state, which launched the political careers of Kennedy’s namesake father and uncles John F. Kennedy and Edward Kennedy.

“The Kennedy name is still strong and has a lot of lasting power in the Bay State,” said Brad Bannon, longtime Massachusetts pollster and CEO of Bannon Communications Research. “It’s smart politics for Kennedy — and Warren and Markey.”

Before he dropped his own presidential bid over the summer, Kennedy was polling in the high single digits in a matchup with Trump and President Joe Biden in Massachusetts. He ultimately did not appear on the state’s ballot.

Markey and Warren voted for very few of Trump’s first term nominees, even compared with their other Democratic colleagues.

A Markey spokesperson said the senator is “hearing from his constituents about Mr. Kennedy’s nomination, as well as all of Trump’s nominees,” and that he’s meeting with many other nominees.

Markey, who upset one of Kennedy’s nephews, Joseph P. Kennedy III, to win his Senate seat in 2020, haspreviously said Kennedy is an “unqualified, unserious and dangerous” choice for HHS. And Warren has saidshe would laugh at the nomination “if it weren’t so scary.”

Even many of Kennedy’sown family members have decried his run for president and later endorsement of Trump.

But the Kennedy legacy remains strong — even beyond Massachusetts.

Sen. John Cornyn (R-Texas), who sits on the Finance Committee that will have to approve Kennedy’s nomination before it goes to the Senate floor, told reporters that he and Kennedy had “some interesting conversations” about the senator’s experience with Kennedy’s uncle Edward, who served as a Massachusetts senator for nearly five decades and was the second-most senior senator when he died in 2009.

He was “sort of the lion of the Senate back when I first got here,” Cornyn said. “And what a larger than life personality he was.”

An evangelist for treating mental health disorders with psychedelic drugs whom President Joe Biden appointed to a top job at the VA wants to join forces with Robert F. Kennedy Jr.

Dr. Shereef Elnahal told Blue Light News his own interest in the drugs dovetails with that of Kennedy, President-elect Donald Trump’s pick to lead the Department of Health and Human Services, and that he wants to continue overseeing the health portfolio at the VA.

“I haven’t been asked to stay, but if I am asked, I would stay,” Elnahal told Blue Light News. “I’d be honored to continue on and advance the agenda for veterans.”

The Department of Veterans Affairs runs the largest health system in the country, serving more than 9 million veterans.

Elnahal’s popular among veterans and psychedelics advocates, who say they are making calls this week to encourage lawmakers to lobby Trump to keep Elnahal on.

The odds of that are long. Trump has largely tapped loyalists and celebrities to staff his administration.

While Trump hasn’t publicly commented on psychedelics, Elnahal is heartened by what he’s heard from Kennedy, who has openly criticized the Food and Drug Administration’s approach to regulating the mind-altering drugs. The FDA this summer rejected a drugmaker’s application to offer the psychedelic drug MDMA, alongside therapy, as a post-traumatic stress disorder treatment.

“The public statements from Bobby Kennedy on this have been very encouraging,” Elnahal said.

Kennedy said his mind was open “to the idea of psychedelics for treatment,” in a post to X in September, adding that “People ought to have the freedom and the liberty to experiment with these hallucinogens to overcome debilitating disorders.”

Still, some are skeptical that the hype around psychedelic medicine has outpaced the science behind it, and worry that the drugs could be misused or could put patients at risk.

The incoming administration has the chance to push psychedelic therapy forward, Elnahal argued, and he wants to be a part of that. If he remains in his role at VA, he said he’d advance the field by growing the agency’s psychedelics research portfolio and, if there’s White House and veteran support, expand the use of psychedelic therapy for veterans in safe settings, alongside ongoing clinical trials.

“I really appreciate Bobby Kennedy’s approach to trying to instill wellness as a bigger part of American life — I think veterans would benefit from that,” Elnahal said, adding, “When it comes to breakthrough therapies for mental health and tackling veteran suicide, psychedelics fall straight into that agenda.”

Why it matters: A year ago, the VA announced it would fund psychedelic research on post-traumatic stress disorder and depression for the first time since the 1960s.

In addition to being the largest health system in the country, the VA serves a population with disproportionately high PTSD rates. Nearly 17 veterans die each day by suicide, according to the VA.

Thousands of veterans, many of whom have PTSD or depression, travel to other countries to seek psychedelic-assisted therapy each year.

Given that, Elnahal thinks the United States should be offering those therapies in well-controlled settings.

“The only way to do that is to boldly approach this with more research and to give veterans access to this kind of therapy here at home,” he said. “You shouldn’t have to travel to Mexico. You shouldn’t have to travel to Costa Rica. We really need a line of sight into this type of therapy to make sure that it’s effective.”

“The incoming administration has the right mindset on developing that evidence and delivering it safely to veterans,” he added.

What’s next: The VA’s research will continue regardless of whether Elnahal keeps his job. Studies are ongoing and millions of dollars in VA-funded psychedelics research are slated to be awarded next year.

But if Trump replaces Elnahal, those who have worked with the undersecretary say it will take more effort to advance psychedelics without him.

Senate Majority Leader John Thune sparked commotion around Blue Light News with his ambitious 2025 calendar, which included regular Friday votes, something of a rarity in the chamber.

Now it’s the first full session week under the new GOP majority, and senators appear poised to go home on — reader, sit down for this — Thursday.

So are Republicans already reneging on their go-go scheduling?

Not exactly: There would have been a Friday vote on a GOP immigration bill had Democrats not agreed to yield back debate time. That sort of exchange happens from time to time in the Senate, particularly when the fate of a bill is certain — as it is with the Laken Riley Act, which will garner significant Democratic support. There are also special circumstances this week, with snowstorms moving across swaths of the U.S., and fires ravaging southern California.

But expect this week’s tango to become commonplace, with peer pressure weighing on Democrats to speed up votes on Republican priorities, essentially allowing the GOP majority to stuff five days’ work into four.

What else we’re watching: There is another unusual element of Thune’s Senate calendar: 10 straight weeks in session to kick off the year, a far longer stretch than the chamber is used to. Typically each chamber schedules one recess week (ahem, “state work period”) per month.

Members tend to get grouchy, if we’re being frank, when kept in D.C. for extended stretches. That especially applies to West Coast members who don’t always take weekly trips back home. We could see a world in which Thune tries to give them a hall pass of sorts, finagling the legislative schedule to allow for an extra long weekend sometime between now and March.